Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

AstraZeneca announced that its drug Lynparza (olaparib) has been approved for use in Scotland. The approval by the Scottish ...

Olaparib plus abiraterone improved survival vs placebo in BRCA-mutated metastatic castration-resistant prostate cancer.

Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.

Muhle is one of many supporters of Legislative Bill 338 from State Sen. Dave “Woody” Wordekemper of Fremont, which seeks to ...

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

University of Massachusetts Amherst cancer researchers hope to change that by developing a new, noninvasive test that uses women's breast milk to detect breast cancer in its earliest stages. New ...

Testing has increased tenfold over the past decade for mutations in the BRCA2 gene, which along with BRCA1 is considered a significant predictor of inherited breast cancer risks. Mutations in ...

The Bachelorette alumna Katie Thurston took to Instagram today to share that she has been diagnosed with breast cancer.

A local radio host is encouraging Tucsonans to consider genetic testing after it played a critical role in her own health ...

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

Jewish Genetic Screening Awareness Week is very important in educating the public and advocating for widespread screening.